5-ASA Agent (Inflammatory Bowel Disease)Conditionally Approved

Mesalamine

Brand names: Asacol, Lialda, Pentasa|Last verified: 2026-03-01

FAA Pathway: Special Issuance — depends on IBD severity

Mesalamine for ulcerative colitis or Crohn's disease may be conditionally approved. The medication itself is not on the DNI list, but the underlying IBD severity and symptom control determine the certification pathway.

Check your medications

Look up any medication in our FAA compatibility database.

Medication Checker

Pilot Tip

Always report all medications on your FAA medical application (Form 8500-8, Item 17a), even OTC medications. Failure to disclose is a far bigger issue than the medication itself.

Certification Details

Key Requirements
IBD in remission or well-controlled
Certificate Classes
Depends on IBD severity and symptom control
Monitoring
GI follow-up documentation
Notes
Active flares with unpredictable symptoms may be disqualifying

Sources

  • FAA AME Guide, Gastroenterology

Last verified: 2026-03-01

Frequently Asked Questions

Is Mesalamine allowed for pilots?

The FAA considers Mesalamine (Asacol, Lialda, Pentasa) to be "Conditionally Approved" for medical certification purposes. Mesalamine for ulcerative colitis or Crohn's disease may be conditionally approved. The medication itself is not on the DNI list, but the underlying IBD severity and symptom control determine the certification pathway.

What is the FAA status of Mesalamine?

Mesalamine has a status of "Conditionally Approved" under FAA medical certification policy. The certification pathway is: Special Issuance — depends on IBD severity.

Can I fly while taking Mesalamine?

Flying while taking Mesalamine may be possible through the FAA's Special Issuance process. You will need to meet specific requirements and obtain approval before exercising pilot privileges. Consult an experienced AME for guidance.

Important Notice

The FAA does not publish a comprehensive list of “approved” medications. The information on this page represents our interpretation of publicly available FAA guidance and is provided for informational and educational purposes only. It does not constitute medical advice, legal advice, or a guarantee of certification outcome.

The primary issue with the FAA is always whether the underlying medical condition — not just the medication — is compatible with safe flight. You should only start, stop, or change medications after consulting your treating physician. Always consult with a qualified Aviation Medical Examiner (AME) for guidance specific to your situation. FAA policies are subject to change. ClearedMed is not affiliated with or endorsed by the FAA.